|Videos|December 13, 2022

CheckMate 9ER: Real World and Health-Related Quality of Life Outcomes

Dr Jonasch shares his perspective on CheckMate 9ER in the real-world setting and discusses the trial’s health-related quality-of-life outcomes data investigating nivolumab plus cabozantinib in advanced renal cell carcinoma treatment.


Latest CME